Follow
Rita Mancini
Rita Mancini
Ricercatore MED05 " La Sapienza"
Verified email at uniroma1.it
Title
Cited by
Cited by
Year
Li4Ti5O12 as anode in all-solid-state, plastic, lithium-ion batteries for low-power applications
PP Prosini, R Mancini, L Petrucci, V Contini, P Villano
Solid State Ionics 144 (1-2), 185-192, 2001
3132001
Muir–Torre-like syndrome in Fhit-deficient mice
LYY Fong, V Fidanza, N Zanesi, LF Lock, LD Siracusa, R Mancini, ...
Proceedings of the National Academy of Sciences 97 (9), 4742-4747, 2000
2662000
FHIT gene therapy prevents tumor development in Fhit-deficient mice
KR Dumon, H Ishii, LYY Fong, N Zanesi, V Fidanza, R Mancini, ...
Proceedings of the National Academy of Sciences 98 (6), 3346-3351, 2001
2172001
The tumor spectrum in FHIT-deficient mice
N Zanesi, V Fidanza, LY Fong, R Mancini, T Druck, M Valtieri, T Rüdiger, ...
Proceedings of the National Academy of Sciences 98 (18), 10250-10255, 2001
2082001
Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ
A Noto, C De Vitis, ME Pisanu, G Roscilli, G Ricci, A Catizone, ...
Oncogene 36 (32), 4573-4584, 2017
1842017
Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells
A Noto, S Raffa, C De Vitis, G Roscilli, D Malpicci, P Coluccia, A Di Napoli, ...
Cell death & disease 4 (12), e947-e947, 2013
1662013
Metabolic features of cancer stem cells: the emerging role of lipid metabolism
R Mancini, A Noto, ME Pisanu, C De Vitis, M Maugeri-Saccà, G Ciliberto
Oncogene 37 (18), 2367-2378, 2018
1272018
miR-579-3p controls melanoma progression and resistance to target therapy
L Fattore, R Mancini, M Acunzo, G Romano, A Laganà, ME Pisanu, ...
Proceedings of the National Academy of Sciences 113 (34), E5005-E5013, 2016
1232016
Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells
ME Pisanu, A Noto, C De Vitis, S Morrone, G Scognamiglio, G Botti, ...
Cancer letters 406, 93-104, 2017
1202017
MicroRNAs in melanoma development and resistance to target therapy
L Fattore, S Costantini, D Malpicci, CF Ruggiero, PA Ascierto, CM Croce, ...
Oncotarget 8 (13), 22262, 2017
1042017
Age is not the only risk factor in COVID-19: the role of comorbidities and of long staying in residential care homes
M D’ascanio, M Innammorato, L Pasquariello, D Pizzirusso, G Guerrieri, ...
BMC geriatrics 21, 1-10, 2021
972021
The promise of anti-ErbB3 monoclonals as new cancer therapeutics
L Aurisicchio, E Marra, G Roscilli, R Mancini, G Ciliberto
Oncotarget 3 (8), 744, 2012
942012
Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Eμ-TCL1 transgenic mice
N Zanesi, R Aqeilan, A Drusco, M Kaou, C Sevignani, S Costinean, ...
Cancer research 66 (2), 915-920, 2006
902006
Circulating lymphocyte subsets in human acute pancreatitis
R Pezzilli, P Billi, E Beltrandi, M Maldini, R Mancini, AMM Labate, ...
Pancreas 11 (1), 95-100, 1995
891995
SCD1, autophagy and cancer: implications for therapy
F Ascenzi, C De Vitis, M Maugeri-Saccà, C Napoli, G Ciliberto, R Mancini
Journal of Experimental & Clinical Cancer Research 40 (1), 265, 2021
882021
Decreased expression of autophagic beclin 1 protein in idiopathic pulmonary fibrosis fibroblasts
A Ricci, E Cherubini, D Scozzi, V Pietrangeli, L Tabbì, S Raffa, L Leone, ...
Journal of Cellular Physiology 228 (7), 1516-1524, 2013
832013
Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax Expression in Invasive and in Situ Squamous Cell Carcinoma of the Uterine Cervix
EGRMTPMAA Vecchione
Clinical cancer research 6 (9), 3600-3606, 2000
822000
Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway
A Leone, MS Roca, C Ciardiello, M Terranova-Barberio, C Vitagliano, ...
Free Radical Biology and Medicine 89, 287-299, 2015
812015
Investigation into the coupling of micro gas turbines with CSP technology: OMSoP project
M Lanchi, M Montecchi, T Crescenzi, D Mele, A Miliozzi, V Russo, ...
Energy Procedia 69, 1317-1326, 2015
802015
Oral zinc supplementation in Down's syndrome subjects decreased infections and normalized some humoral and cellular immune parameters
F Licastro, M Chiricolo, E Mocchegiani, N Fabris, M Zannoti, E Beltrandi, ...
Journal of Intellectual Disability Research 38 (2), 149-162, 1994
801994
The system can't perform the operation now. Try again later.
Articles 1–20